The Vaccine Vector Design Team designs, generates, and characterizes innovative viral vaccines that target emerging infectious diseases. Our primary focus is on creating recombinant vesicular stomatitis virus (VSV)-based vaccine vectors. Additionally, we develop analytical assays to assess viral vectors and vaccine materials. The team is also responsible for producing materials compliant with current good manufacturing practice (cGMP) regulations and will provide support for preclinical studies and clinical product development.